![]() Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. | ||
Founding Date | Founding Date 2009 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | |
Employees | Employees 4843% increase | Employees 82517% decrease |
Valuation ($) | Valuation ($) 10.6 m | Valuation ($) 648.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $148.8m (FY, 2021) | Revenue (est.) €535.2m (FY, 2024) |
Net income | Net income ($264.5m) (FY, 2021) | Net income €162.2m (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 357m | Total funding raised $ 1.1b |

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company